New weight-loss drugs promise transformative benefits, but soaring demand and massive cost projections leave Ireland facing ...

But even as Ozempic enters India, there is a growing sense globally that Novo may have already lost the obesity drug war to Mounjaro, Eli Lilly’s blockbuster that has become India’s top-selling drug ...

Novo Nordisk has launched its blockbuster diabetes drug Ozempic in India, pricing the starter dose at ₹8,800 per month (₹2,200 per week), positioning it as a competitor to Eli Lilly's Mounjaro (priced ...

Jelly Roll, Ashley Tisdale, Chrissy Teigen, Meghan Trainor and more celebs who've talked about semaglutide drugs including ...

Danish drugmaker Novo Nordisk will launch its blockbuster diabetes drug Ozempic in India this month, three sources familiar ...

We never know what demons other people are fighting, even if we think we see their problems from the outside. Those who ...

We knew that GLP-1 drugs like Ozempic and Wegovy did more than just help control type 2 diabetes and aid weight loss, but the ...

Obesity is a big driver of healthcare spending in South Africa, yet most medical schemes still limit cover for effective ...

As GLP-1 therapies gain momentum globally and in India, Novo Nordisk’s launch of Ozempic signals a deeper push to capture the ...

Danish drugmaker Novo Nordisk will launch its blockbuster diabetes drug Ozempic in India this month, three sources familiar ...

In an interview, Novo Nordisk India’s managing director Vikrant Shrotriya discusses the launch of Ozempic, the company’s ...

According to last year’s National Food and Nutrition Society Survey, 31% of men and 68% of women in South Africa are ...